Curcumin: a double hit on malignant mesothelioma.

Area of Science:

• Oncology
• Immunology
• Natural Product Chemistry

Background:

• Malignant mesothelioma is an aggressive cancer with limited treatment options.
• Inflammation plays a critical role in mesothelioma development.
• Curcumin, a turmeric polyphenol, exhibits anti-cancer and anti-inflammatory effects.

Purpose of the Study:

• To investigate the role of curcumin in inducing pyroptosis in malignant mesothelioma cells.
• To elucidate the molecular mechanisms underlying curcumin's effects on mesothelioma cells.
• To assess curcumin's potential as a therapeutic agent for malignant mesothelioma.

Main Methods:

• In vitro studies using mouse and human mesothelioma cell lines.
• Analysis of caspase-1 activation, pyroptosis markers (e.g., HMGB1 release), and cytokine processing (IL-1β, IL-18).
• Investigation of the NF-κB pathway, oxidant dependence (using N-acetyl-L-cysteine), and inflammasome gene expression (PCR array).

Main Results:

• Curcumin induced pyroptosis via caspase-1 activation and HMGB1 release, independent of IL-1β and IL-18 processing.
• NF-κB pathway inhibition by curcumin blocked IL-1β priming, preventing its processing.
• Curcumin-induced cytotoxicity was dependent on pyroptosis, and its activation required oxidants.
• Curcumin downregulated inflammasome-related genes, including NF-κB, TLRs, and IL-1β.

Conclusions:

• Curcumin effectively induces pyroptotic cell death in malignant mesothelioma cells.
• Curcumin exerts a dual effect by promoting pyroptosis and reducing inflammation.
• These findings highlight curcumin's potential therapeutic value against malignant mesothelioma.